Are you Dr. Johnson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 626
Rochester, NY 14642Phone+1 585-276-3087Fax+1 585-273-1027
Summary
- Dr. Mahlon Johnson, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Tennessee. He is affiliated with Strong Memorial Hospital of the University of Rochester and is a Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
- Vanderbilt University Medical CenterFellowship, Neuropathology, 1987 - 1989
- Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1989
- University of Tennessee Health Science Center College of MedicineClass of 1981
Certifications & Licensure
- TN State Medical License 1981 - 2026
- NY State Medical License 2006 - 2025
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Low-grade fibromyxoid tumor of the dura: A new entity?Mahlon Johnson, Howard Silberstein, David Korones, Ali Hussain, Debra Hawes
Surgical Neurology International. 2024-01-01 - 11 citationsClinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines...Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, Guomiao Shen, Ivy Tran
Neuro-Oncology Advances. 2023-06-26 - Carotid Intimal Sarcoma Presenting as Large Vessel Occlusion and Diagnosed by Embolus Histopathology: Case Report.Mahlon D Johnson, Eli J Rogers, Muhammad Waqas Khan, Phillip D McMullen, Sajal Medha K Akkipeddi
Neurology. Clinical Practice. 2023-02-01
Press Mentions
- Low-Grade Fibromyxoid Tumor of the Dura: A New Entity?February 18th, 2024